Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
-6.16M
-
Total reported value, excl. options
-
$268M
-
Value change
-
-$12M
-
Put/Call ratio
-
0
-
Number of buys
-
69
-
Number of sells
-
-43
-
Price
-
$1.92
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q4 2022
138 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q4 2022.
Nuvation Bio Inc. - Common Stock (NUVB) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
of 339M outstanding shares and own 41.13% of the company stock.
Largest 10 shareholders include FMR LLC (26.5M shares), Omega Fund Management, LLC (15.1M shares), EcoR1 Capital, LLC (13.9M shares), BlackRock Inc. (11M shares), VANGUARD GROUP INC (9.93M shares), Deep Track Capital, LP (8.22M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.85M shares), CITADEL ADVISORS LLC (5.32M shares), BAUPOST GROUP LLC/MA (4.81M shares), and BRAIDWELL LP (4.12M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.